Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: Implications for susceptibility to spondylarthropathies

Journal of Clinical Investigation

Volumn 98, Issue 12, 1996, Pages 2764-2770

  Boisgérault, Florence ^b   Tieng, Vannary ^b   Stolzenberg, Marie Claude ^b   Dulphy, Nicolas ^b   Khalil, Iman ^b   Tamouza, Ryad ^b   Charron, Dominique ^b   Toubert, Antoine ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

Amino acid sequence; Autoimmune diseases; Enterobacteriaceae; HLA B27; Peptides; Spondylitis, ankylosing

Indexed keywords

HLA B27 ANTIGEN;

ALLELISM; ANTIGEN DETECTION; ARTICLE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPONDYLOARTHROPATHY;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; B-LYMPHOCYTES; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HLA ANTIGENS; HLA-B27 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; SEQUENCE ANALYSIS; SPONDYLITIS, ANKYLOSING; TRANSFECTION;

EID: 0030455722     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119102     Document Type: Article

References (41)

1. Brewerton, D., F. Hart, A. Nicholls, M. Caffrey, D.C.O. James, and R.D. Sturrock. 1973. Ankylosing spondylitis and HLA-27. Lancet. I:904-907.
2. Schlosstein, L., P.I. Terasaki, R. Bluestone, and C.M. Pearson. 1973. High association of an HLA antigen, w27, with ankylosing spondilytis. N. Engl. J. Med. 288:704-706.
3. Lopez de Castro, J.A. 1996. HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility. Clin. Rheumatol. 15:67-71.
4. Burmester, G.R., A. Daser, T. Kamradt, A. Krause, N.A. Mitchison, J. Sieper, and N. Wolf. 1995. Immunology or reactive arthritides. Annu. Rev. Immunol. 13:229-250.
5. Bodmer, J.G., S.G.E. Marsh, E.D. Albert, W.F. Bodmer, R.E. Bontrop, D. Charron, B. Dupont, H.A. Erlich, W.R. Mayr, P. Parham, T. Sasazuki, G.M.T. Schreuder, J.L. Strominger, A. Svejgaard, and P.I. Terasaki. 1995. Nomenclature for factors of the HLA system, 1995. Tissue Antigens. 46:1-18.
6. Hill, A.V.S., C.E.M. Allsopp, D. Kwiatkowski, N.M. Ansley, B.M. Greenwood, and A.J. McMichael. 1991. HLA-B27 and an African B27 subtype. Lancet. 337:640-642.
7. Lopez-Larrea, C., K. Sujirachato, N.K. Mehra, P. Chiewsilp, D. Isarangkura, U. Kanga, O. Domingez, E. Coto, M. Pena, F. Setien, and S. Gonzalez-Roces. 1995. HLA-B27 subtype in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens. 45:169-176.
8. D'Amato, M., M.T. Fiorillo, C. Carcassi, A. Mathieu, A. Zucarelli, P.P. Bitti, R. Tosi, and R. Sorrentino. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25:3199-3201.
9. Toivanen, A., and P. Toivanen. 1995. Epidemiologic, clinical and therapeutic aspects of reactive arthritis and ankylosing spondylitis. Curr. Opin. Rheumatol. 7: 279-283.
10. Taurog, J., J.A. Richardson, J.T. Croft, W.A. Simmons, M. Zhou, J.L. Fernandez-Sueiro, E. Balish, and R.E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-2364.
11. Villadangos, J.A., B. Galocha, R. Garcia-Hoyo, D. Lopez, F. Garcia, and J.A. Lopez de Castro. 1994. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705. Eur. J. Immunol. 24:2548-2555.
12. Villadangos, J.A., B. Galocha, F. Garcia, J. P. Albar, and J. A. Lopez de Castro. 1995. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur. J. Immunol. 25:2370-2377.
13. Colbert, R.A., S.L. Rowland-Jones, A.J. McMichael, and J. Frelinger. 1994. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity. 1:121-130.
14. Madden, D.R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622.
15. Scofield, R.H., W.L. Warren, G. Koelsch, and J.B. Harley. 1993. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: Contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc. Natl. Acad. Sci. USA. 90:9330-9334.
16. Scofield, R.H., B. Kurien, T. Gross, W.L. Warren, and J.B. Harley. 1995. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet. 345:1542-1544.
17. Rojo, S., F. Garcia, J.A. Villadangos, and J.A. Lopez de Castro. 1993. Changes in the repertoire of peptides hound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. J. Exp. Med. 177:613-620.
18. Toubert, A., C. Raffoux, J. Boretto, J. Sire, R. Sodoyer, S.R. Thurau, B. Amor, F.A. Lemonnier, and B.R. Jordan. 1988. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants. J. Immunol. 141: 2503-2509.
19. Ellis, S.A., C. Taylor, and A.J. McMichael. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5:49-59.
20. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (Lond.). 345:449-452.
21. Boisgérault, F., I. Khalil, V. Tieng, F. Connan, T. Tabary, J.H.M. Cohen, J. Choppin, D. Charron, and A. Toubert. 1996. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc. Natl. Acad. Sci. USA. 93:3466-3470.
22. Falk, K., O. Rötszchke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond). 351:290-296.
23. Stuber, G., S. Modrow, P. Höglund, L. Franksson, J. Elvin, H. Wolf, K. Kärre, and G. Klein. 1992. Assessment of major histocompatibility complex class 1 interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur J. Immunol. 22:2697-2703.
24. van Endert, P., R. Tampé, T.H. Meyer, R. Tisch, J.F. Bach, and H.O. McDevitt. 1994. A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity. 1:491-500.
25. Zemmour, J., A.M. Little, D.J. Schendel, and P. Parham. 1992. The HLA-A, B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148:1941-1948.
26. Suh, W., M. Cohen-Doyle, K. Fruh, K. Wang, P. Peterson, and D. Williams. 1994. Interaction of MHC class I molecules with the transporter associaled with antigen processing. Science (Wash. DC). 264:1322-1326.
27. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196-3206.
28. Rötzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H.-G. Rammersee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics. 39:74-77.
29. Jardetzky, T.S., W.S. Lane, R.A. Robinson, D.R. Madden, and D.C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature (Lond.). 353:326-329.
30. Rognan, D., L. Scapozza, G. Folkers, and A. Daser. 1995. Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. Proc. Natl. Acad. Sci. USA. 92:753-757.
31. Sudo, T., N. Kamikawaji, A. Kimura, Y. Date, C.J. Savoie, H. Nakashima, E. Furuichi, S. Kuhara, and T. Sasazuki. 1995. Differences in MHC class I peptide repertoires among HLA-A2 subtypes. J. Immunol. 155:4749-4756.
32. Barouch, D., T. Friede, S. Stevanovic, L. Tussey, K. Smith, S. Rowland-Jones, V. Braud, A. McMichael, and H.-G. Rammensee. 1995. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182:1847-1856.
33. Wucherpfennig, K.W., and J.L. Strominger. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597-1601.
34. Lopez-Larrea, C., M. V. Alvarez, A. Dieye, L. Housan, and S. Gonzalez-Roces. 1996. HLA-B27 alleles and susceptibility and resistance to AS. Hum. Immunol. 47:73a. (Abstr.)
35. Jiang, L., L.A. Fan, J.Q. Yang, and F.J. Yao. 1996. HLA-B27 subtypes in Chinese patients with ankylosing spondylitis. Hum. Immunol. 47:8a (Abstr.)
36. Taurog, J.D., S.D. Maika, W.A. Simmons, M. Breban, and R.E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168-4178.
37. Khare, S.D., H.S. Luthra, and C. David. 1995. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182:1153-1158.
38. P.M., Allen. 1994. Peptides in positive and negative selection: a delicate balance. Cell 76:593-596.
39. Ignatowicz, L., J. Kappler, and P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell. 84:521-529.
40. Brossart, P., and M.J. Bevan. 1996. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 183:2449-2458.
41. Malnati, M.S., M. Peruzzi, K.C. Parker, W.E. Biddison, E. Ciccone, A. Moretta, and E.O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science (Wash. DC). 267:1016-1018.